RARE has been in the news 375% more than usual
Jan 08, 2026, 3:33 PM
-2.87%
What does RARE do
Ultragenyx Pharmaceutical, based in Novato, California, focuses on developing therapies for rare genetic diseases and has four approved products, including Crysvita and Mepsevii. The company went public on January 31, 2014, and employs 1,276 people.
RARE has been in the news recently: Ultragenyx Pharmaceutical Inc's short interest has decreased by 3.04% to 8.60 million shares, which represents 9.24% of its total float and requires 5.66 days to cover. This change indicates a shift in investor sentiment regarding the company's stock.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.